2009USPSTF阿司匹林用于預防心血管疾病
《2009USPSTF阿司匹林用于預防心血管疾病》內容簡(jiǎn)介：
The USPSTF recommends the use of aspirin for menage 45 to 79 years when the potential benefit due to areduction in myocardial infarctions outweighs the poten-tial harm due to an increase in gastrointestinal hemorrhage.See the Clinical Considerations section for discussion ofbenefits and harms. This is an A recommendation.
《2009USPSTF阿司匹林用于預防心血管疾病》內容預覽：
Recognition of Risk Status
For many groups, available risk calculators can providean accurate estimate of the risk for coronary heart diseaseevents and strokes based on ***rmation about cardiovas-cular risk factors that include sex. See the Clinical Consid-erations section.
Benefits of Preventive Medication
The USPSTF found good evidence that aspirin de-creases the incidence of myocardial infarction in men andischemic strokes in women.
Harms of Preventive Medication
The USPSTF found good evidence that aspirin in-creases the incidence of gastrointestinal bleeding and fairevidence that aspirin increases the incidence of hemor-rhagic strokes.
USPSTF Assessment
The USPSTF concludes that, for men age 45 to 79years whose benefit due to a reduction in myocardial in-farctions exceeds the harm because of an increase in gas-trointestinal bleeding, there is high certainty that the netbenefit is substantial.
點(diǎn)擊下載***：《2009USPSTF阿司匹林用于預防心血管疾病》
本站所注明來(lái)源為"愛(ài)愛(ài)醫"的文章，版權歸作者與本站共同所有，非經(jīng)授權不得轉載。
本站所有轉載文章系出于傳遞更多信息之目的，且明確注明來(lái)源和作者，不希望被轉載的媒體或個(gè)人可與我們
聯(lián)系zlzs@120.net，我們將立即進(jìn)行刪除處理
